Emideltide
Also known as: DSIP, Delta sleep-inducing peptide
Classification
Peptide
Regulatory Status
not-established
Sources
2
Review
n/a
Overview
Emideltide (DSIP) is a nonapeptide historically studied for effects on sleep architecture and delta EEG activity; mechanism remains incompletely defined.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
proposed sleep-regulation neuropeptide effects
Interactions & cautions
Flagged in source data
other unapproved injectable sleep peptides
Drug interactions
sedative-hypnotics and other CNS depressants — Interaction profile is not established; class caution still applies when combining sleep-targeting agents. (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw